{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:02:00Z","timestamp":1790949720581,"version":"4.1.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PZOOP3_161521"],"award-info":[{"award-number":["PZOOP3_161521"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004784","name":"Novartis Stiftung f\u00fcr Medizinisch-Biologische Forschung","doi-asserted-by":"publisher","award":["16B103"],"award-info":[{"award-number":["16B103"]}],"id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010776","name":"OPO-Stiftung","doi-asserted-by":"publisher","award":["2018-0054"],"award-info":[{"award-number":["2018-0054"]}],"id":[{"id":"10.13039\/100010776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2019.00046","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T05:28:12Z","timestamp":1555306092000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":175,"title":["Mouse Models for Atherosclerosis Research\u2014Which Is My Line?"],"prefix":"10.3389","volume":"6","author":[{"given":"Sara","family":"Oppi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokrates","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1161\/01.ATV.0000229218.97976.43","article-title":"Scavenger receptors in atherosclerosis: beyond lipid uptake","volume":"26","author":"Moore","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell."},{"key":"B4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2009.07.002","article-title":"Adaptive immunity and atherosclerosis","volume":"134","author":"Andersson","year":"2010","journal-title":"Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13353-013-0134-4","article-title":"Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation","volume":"54","author":"Mukhopadhyay","year":"2013","journal-title":"J Appl Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.14573\/altex.1406231","article-title":"Alternative methods for the use of non-human primates in biomedical research","volume":"31","author":"Burm","year":"2014","journal-title":"ALTEX."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejphar.2017.05.010","article-title":"Animal models of atherosclerosis","volume":"816","author":"Emini","year":"2017","journal-title":"Eur J Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cmet.2016.11.001","article-title":"Applications and limitations of mouse models for understanding human atherosclerosis","volume":"25","author":"von","year":"2017","journal-title":"Cell Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J Lipid Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/hep.28712","article-title":"Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice","volume":"64","author":"Xu","year":"2016","journal-title":"Hepatology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1028415X.2017.1349359","article-title":"Control diet in a high-fat diet study in mice: regular chow and purified low-fat diet have similar effects on phenotypic, metabolic, and behavioral outcomes","volume":"22","author":"Almeida-Suhett","year":"2017","journal-title":"Nutr Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science."},{"key":"B14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J Clin Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1172\/JCI117179","article-title":"Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice","volume":"93","author":"Ishibashi","year":"1994","journal-title":"J Clin Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCRESAHA.114.302937","article-title":"Induction of atherosclerosis in mice and hamsters without germline genetic engineering","volume":"114","author":"Bjorklund","year":"2014","journal-title":"Circ Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1161\/ATVBAHA.114.303617","article-title":"Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9","volume":"35","author":"Roche-Molina","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1126\/science.272.5262.685","article-title":"Mouse models of atherosclerosis","volume":"272","author":"Breslow","year":"1996","journal-title":"Science."},{"key":"B19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0021-9150(87)90249-8","article-title":"Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL\/6, BALB\/c, and C3H","volume":"64","author":"Paigen","year":"1987","journal-title":"Atherosclerosis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0021-9150(97)00165-2","article-title":"C57BL\/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis","volume":"136","author":"Schreyer","year":"1998","journal-title":"Atherosclerosis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","article-title":"Innate immune response in Th1- and Th2-dominant mouse strains","volume":"22","author":"Watanabe","year":"2004","journal-title":"Shock."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1194\/jlr.R800092-JLR200","article-title":"The role of adaptive T cell immunity in atherosclerosis","volume":"50","author":"Mallat","year":"2009","journal-title":"J Lipid Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler Thromb."},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1365-2796.1997.00197.x","article-title":"The emergence of mouse models of atherosclerosis and their relevance to clinical research","volume":"242","author":"Smith","year":"1997","journal-title":"J Intern Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","article-title":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders","volume":"94","author":"Mahley","year":"2016","journal-title":"J Mol Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/mnfr.200700322","article-title":"Impact of apoE genotype on oxidative stress, inflammation and disease risk","volume":"52","author":"Jofre-Monseny","year":"2008","journal-title":"Mol Nutr Food Res."},{"key":"B27","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/S0022-2275(20)39713-3","article-title":"Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice","volume":"36","author":"Tangirala","year":"1995","journal-title":"J Lipid Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-2004-822993","article-title":"Low-density lipoprotein receptor\u2013its structure, function, and mutations","volume":"4","author":"Defesche","year":"2004","journal-title":"Semin Vasc Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1126\/science.1061815","article-title":"Molecular medicine. The cholesterol quartet","volume":"292","author":"Goldstein","year":"2001","journal-title":"Science."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0145102","DOI":"10.1371\/journal.pone.0145102","article-title":"Genetic dissection of tissue-specific apolipoprotein E function for hypercholesterolemia and diet-induced obesity","volume":"10","author":"Wagner","year":"2015","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1073\/pnas.78.12.7545","article-title":"Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E","volume":"78","author":"Basu","year":"1981","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1016\/S0021-9258(18)34141-3","article-title":"Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes","volume":"257","author":"Basu","year":"1982","journal-title":"J Biol Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/ATVBAHA.110.213892","article-title":"Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo","volume":"31","author":"Zanotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1161\/01.ATV.0000243925.65265.3c","article-title":"Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice","volume":"26","author":"Westerterp","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/eurheartj\/ehu319","article-title":"Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin","volume":"36","author":"Kuhnast","year":"2015","journal-title":"Eur Heart J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e13376","DOI":"10.14814\/phy2.13376","article-title":"Male apoE*3-Leiden","volume":"5","author":"Paalvast","year":"2017","journal-title":"Physiol. Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.115.306825","article-title":"Epidemiology of obesity and diabetes and their cardiovascular complications","volume":"118","author":"Bhupathiraju","year":"2016","journal-title":"Circ Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.atherosclerosis.2006.08.030","article-title":"Diabetic atherosclerosis mouse models","volume":"191","author":"Wu","year":"2007","journal-title":"Atherosclerosis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2337\/diab.37.9.1163","article-title":"Diet-induced type II diabetes in C57BL\/6J mice","volume":"37","author":"Surwit","year":"1988","journal-title":"Diabetes."},{"key":"B41","doi-asserted-by":"publisher","first-page":"E207","DOI":"10.1152\/ajpendo.2002.282.1.E207","article-title":"LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice","volume":"282","author":"Schreyer","year":"2002","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/01.ATV.21.3.365","article-title":"Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice","volume":"21","author":"Collins","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1161\/01.CIR.0000092886.52404.50","article-title":"Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes","volume":"108","author":"Phillips","year":"2003","journal-title":"Circulation."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11005\/jbm.2017.24.1.1","article-title":"Role of the cytokine-like hormone leptin in muscle-bone crosstalk with aging","volume":"24","author":"Hamrick","year":"2017","journal-title":"J Bone Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.apjtm.2017.09.003","article-title":"Food intake regulation by leptin: mechanisms mediating gluconeogenesis and energy expenditure","volume":"10","author":"Hussain","year":"2017","journal-title":"Asian Pac J Trop Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cyto.2016.10.011","article-title":"Leptin in inflammation and autoimmunity","volume":"98","author":"La","year":"2017","journal-title":"Cytokine."},{"key":"B47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2005.01.029","article-title":"Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor","volume":"181","author":"Wu","year":"2005","journal-title":"Atherosclerosis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1242\/dmm.003467","article-title":"Mouse models of the metabolic syndrome","volume":"3","author":"Kennedy","year":"2010","journal-title":"Dis Model Mech."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1006\/bbrc.1994.1883","article-title":"Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice","volume":"201","author":"Hayek","year":"1994","journal-title":"Biochem Biophys Res Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.bbrc.2005.02.090","article-title":"Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility","volume":"329","author":"Tian","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.neurobiolaging.2004.02.030","article-title":"Distinct signaling mechanisms for apoE inhibition of cell migration and proliferation","volume":"26","author":"Hui","year":"2005","journal-title":"Neurobiol Aging."},{"key":"B53","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0022-2275(20)34910-5","article-title":"Identification and characterization of LRP8 (apoER2) in human blood platelets","volume":"40","author":"Riddell","year":"1999","journal-title":"J Lipid Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1172\/JCI97950","article-title":"The role of non-resolving inflammation in atherosclerosis","volume":"128","author":"Kasikara","year":"2018","journal-title":"J Clin Invest."},{"key":"B55","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.4049\/jimmunol.173.10.6366","article-title":"Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice","volume":"173","author":"Grainger","year":"2004","journal-title":"J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin Microbiol Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1161\/CIRCULATIONAHA.109.872663","article-title":"Impaired fibrillin-1 function promotes features of plaque instability in apolipoprotein E-deficient mice","volume":"120","author":"Van","year":"2009","journal-title":"Circulation."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/eurheartj\/ehu041","article-title":"Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death","volume":"36","author":"Van","year":"","journal-title":"Eur Heart J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroscience.2015.03.023","article-title":"Fibrillin-1 impairment enhances blood-brain barrier permeability and xanthoma formation in brains of apolipoprotein E-deficient mice","volume":"295","author":"Van","year":"","journal-title":"Neuroscience."},{"key":"B60","doi-asserted-by":"publisher","first-page":"986","DOI":"10.5551\/jat.13391","article-title":"Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration\/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe","volume":"19","author":"Sato","year":"2012","journal-title":"J Atheroscler Thromb."},{"key":"B61","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/MOL.0b013e3283646e4d","article-title":"Mouse models of plaque rupture","volume":"24","author":"Matoba","year":"2013","journal-title":"Curr Opin Lipidol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/CIRCULATIONAHA.117.029002","article-title":"Long noncoding RNA facilitated gene therapy reduces atherosclerosis in a murine model of familial hypercholesterolemia","volume":"136","author":"Tontonoz","year":"2017","journal-title":"Circulation."},{"key":"B63","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature17674","article-title":"Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis","volume":"534","author":"Sallam","year":"2016","journal-title":"Nature."},{"key":"B64","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nm.4479","article-title":"Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA","volume":"24","author":"Sallam","year":"2018","journal-title":"Nat Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s42255-018-0004-9","article-title":"The long noncoding RNA CHROME regulates cholesterol homeostasis in primates","volume":"1","author":"Hennessy","year":"2019","journal-title":"Nat Metab."},{"key":"B66","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nature03988","article-title":"A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma","volume":"437","author":"Pascual","year":"2005","journal-title":"Nature."},{"key":"B67","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1101\/gad.545110","article-title":"GPS2-dependent corepressor\/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response","volume":"24","author":"Venteclef","year":"2010","journal-title":"Genes Dev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cmet.2014.07.023","article-title":"SUMOylation-dependent LRH-1\/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport","volume":"20","author":"Stein","year":"2014","journal-title":"Cell Metab."},{"key":"B69","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1172\/JCI85499","article-title":"Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease","volume":"127","author":"Stein","year":"2017","journal-title":"J Clin Invest."},{"key":"B70","doi-asserted-by":"publisher","first-page":"12102","DOI":"10.1073\/pnas.1814522115","article-title":"PPARgamma-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice","volume":"115","author":"Katafuchi","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/eurheartj\/ehw025","article-title":"CardioPulse: translational research in cardiovascular disease","volume":"37","author":"Stein","year":"2016","journal-title":"Eur Heart J."},{"key":"B72","doi-asserted-by":"publisher","first-page":"37751","DOI":"10.18632\/oncotarget.17154","article-title":"CRISPR\/Cas9-mediated ApoE-\/- and LDLR-\/- double gene knockout in pigs elevates serum LDL-C and TC levels","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget."},{"key":"B73","doi-asserted-by":"publisher","first-page":"44624","DOI":"10.1038\/srep44624","article-title":"Somatic genome editing with CRISPR\/Cas9 generates and corrects a metabolic disease","volume":"7","author":"Jarrett","year":"2017","journal-title":"Sci Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"dmm036632","DOI":"10.1242\/dmm.036632","article-title":"Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs","volume":"11","author":"Fang","year":"2018","journal-title":"Dis Model Mech."},{"key":"B75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ebiom.2018.09.020","article-title":"Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7","volume":"36","author":"Lu","year":"2018","journal-title":"EBioMedicine."},{"key":"B76","doi-asserted-by":"publisher","first-page":"dmm033852","DOI":"10.1242\/dmm.033852","article-title":"A severe atherosclerosis mouse model on the resistant NOD background","volume":"11","author":"Wang","year":"2018","journal-title":"Dis Model Mech."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2019.00046\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T19:55:12Z","timestamp":1663271712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2019.00046\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":76,"alternative-id":["10.3389\/fcvm.2019.00046"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2019.00046","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"article-number":"46"}}